review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1010944012 |
P356 | DOI | 10.1385/JMN:26:2-3:245 |
P698 | PubMed publication ID | 16012198 |
P2093 | author name string | Fang Liu | |
Frank J S Lee | |||
Yu-tian Wang | |||
P2860 | cites work | The dopamine D2 receptor: two molecular forms generated by alternative splicing | Q24305916 |
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1 | Q24313045 | ||
Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine | Q24319813 | ||
Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors | Q28144080 | ||
Human dopamine D1 receptor encoded by an intronless gene on chromosome 5 | Q28258672 | ||
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics | Q28258681 | ||
Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain | Q28276882 | ||
Localization of the D5 dopamine receptor gene to human chromosome 4p15.1-p15.3, centromeric to the Huntington's disease locus | Q28278580 | ||
Modulatory actions of dopamine on NMDA receptor-mediated responses are reduced in D1A-deficient mutant mice | Q28510955 | ||
Cloning and expression of a rat D2 dopamine receptor cDNA | Q28567326 | ||
Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32 | Q28570233 | ||
Potentiation of NMDA receptor currents by dopamine D1 receptors in prefrontal cortex | Q28575970 | ||
Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor | Q28577705 | ||
Selective up-regulation of dopamine D1 receptors in dendritic spines by NMDA receptor activation | Q28577907 | ||
Developing a neuronal model for the pathophysiology of schizophrenia based on the nature of electrophysiological actions of dopamine in the prefrontal cortex | Q33702820 | ||
The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum | Q33862978 | ||
Regulation of NMDA Receptors by Dopamine D4Signaling in Prefrontal Cortex | Q34273323 | ||
Dopamine neurons make glutamatergic synapses in vitro. | Q34470528 | ||
Selective modulation of excitatory and inhibitory microcircuits by dopamine | Q34808734 | ||
Multiple D2 dopamine receptors produced by alternative RNA splicing | Q35164518 | ||
The major dopamine D2 receptor: molecular analysis of the human D2A subtype | Q35351787 | ||
Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions | Q35610979 | ||
Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines | Q36588914 | ||
Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated | Q36599964 | ||
The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-D-aspartate responses | Q36833070 | ||
Dopamine receptor subtypes modulate olfactory bulb gamma-aminobutyric acid type A receptors | Q37188153 | ||
Dendritic release of dopamine in the substantia nigra | Q40123417 | ||
Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors. | Q40662659 | ||
Dopamine neurons and their role in reward mechanisms | Q40899058 | ||
Parkinson's disease: prospects for improved drug therapy | Q41498407 | ||
Dopamine D1 receptors facilitate GABAA synaptic currents in the rat substantia nigra pars reticulata. | Q41712778 | ||
Increase of extracellular dopamine in primate prefrontal cortex during a working memory task | Q42446499 | ||
Modulation of inhibitory transmission by dopamine in rat basal forebrain nuclei: activation of presynaptic D1-like dopaminergic receptors. | Q42527100 | ||
Direct inhibition of the N-methyl-D-aspartate receptor channel by dopamine and (+)-SKF38393. | Q42603795 | ||
Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. | Q43683702 | ||
A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission | Q44158663 | ||
Dopamine enhances EPSCs in layer II-III pyramidal neurons in rat prefrontal cortex. | Q44306940 | ||
Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors. | Q44755344 | ||
Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum | Q46717751 | ||
Corelease of two fast neurotransmitters at a central synapse. | Q47837764 | ||
Heterogeneous distribution of D1, D2 and D5 receptor mRNAs in monkey striatum | Q48249521 | ||
A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor. | Q48329693 | ||
Influence of reward expectation on behavior-related neuronal activity in primate striatum | Q48410948 | ||
Localization of multiple dopamine receptor subtype mRNAs in human and monkey motor cortex and striatum | Q48428539 | ||
Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area | Q48469772 | ||
Dopamine D1-like receptors and reward-related incentive learning | Q48474345 | ||
D5 dopamine receptors enhance Zn2+-sensitive GABA(A) currents in striatal cholinergic interneurons through a PKA/PP1 cascade | Q48589850 | ||
Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum | Q48657980 | ||
A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. | Q48658263 | ||
Interactions between excitatory amino acids and dopamine systems in the forebrain: implications for schizophrenia and Parkinson's disease. | Q48798732 | ||
In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other | Q48896592 | ||
Localization of monoamines in the lower brain stem. | Q51272663 | ||
Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop | Q56093340 | ||
Convergence of hippocampal and dopaminergic input onto identified neurons in the nucleus accumbens of the rat | Q69375075 | ||
Distribution of dopamine D1, D2, and D5 receptor mRNAs in the monkey brain: ribonuclease protection assay analysis | Q71521102 | ||
Input from the amygdala to the rat nucleus accumbens: its relationship with tyrosine hydroxylase immunoreactivity and identified neurons | Q71671103 | ||
Silencing of the constitutive activity of the dopamine D1B receptor. Reciprocal mutations between D1 receptor subtypes delineate residues underlying activation properties | Q71763122 | ||
Dopamine D5 receptor agonist high affinity and constitutive activity profile conferred by carboxyl-terminal tail sequence | Q73783863 | ||
Dopamine D(5) receptor immunolocalization in rat and monkey brain | Q73955612 | ||
The occurrence, distribution and physiological role of catecholamines in the nervous system | Q78711372 | ||
P433 | issue | 2-3 | |
P304 | page(s) | 245-252 | |
P577 | publication date | 2005-01-01 | |
P1433 | published in | Journal of Molecular Neuroscience | Q15708870 |
P1476 | title | Direct receptor cross-talk can mediate the modulation of excitatory and inhibitory neurotransmission by dopamine | |
P478 | volume | 26 |
Q40251616 | Association of the mu-opioid receptor gene with smoking cessation |
Q37773024 | Brain receptor mosaics and their intramembrane receptor-receptor interactions: molecular integration in transmission and novel targets for drug development |
Q36542313 | Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications |
Q36577320 | Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease |
Q42050477 | Extrasynaptic neurotransmission in the modulation of brain function. Focus on the striatal neuronal-glial networks. |
Q90031876 | Neurobehavioural complications of sleep deprivation: Shedding light on the emerging role of neuroactive steroids |
Q37955871 | Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts |
Q48265009 | The neuroprotective effect of propofol against brain ischemia mediated by the glutamatergic signaling pathway in rats |
Q38182660 | The pathomechanisms underlying Parkinson's disease |
Q28087558 | The role of transmitter diffusion and flow versus extracellular vesicles in volume transmission in the brain neural-glial networks |
Search more.